A systematic review on diagnostic challenges and burden related to idiopathic hypersomnia gave insights into the extensive difficulties associated with the condition. “Idiopathic hypersomnia (IH ...

Researchers in the US surveyed hundreds of people to get the estimate They said 1.5 percent of participants had the condition 'idiopathic hypersomnia' READ MORE: Now the CDC claims 3.3million ...

A sleep disorder that scientists previously believed was rare might be more common than originally thought. The condition is ...

These quiz questions about idiopathic hypersomnia (IH) are derived from current literature. Are you up to date? At the end of the quiz, compare your score with those of your physician colleagues.

With idiopathic hypersomnia, it’s hard to get to a diagnosis, much less an effective treatment. Learn what you need to know to take control of your care.

New Report Illuminates the Real-World Experiences and Treatment Needs of Individuals with Idiopathic Hypersomnia WEST PALM BEACH, Fla., Sept. 17, 2024 /PRNewswire/ -- The Sleep Consortium ...

Mizuho Securities analyst Uy Ear has maintained their bullish stance on ALKS stock, giving a Buy rating on September 26. Uy Ear has given his ...

Presentation Details Oral Presentation Title: Safety and Efficacy of KP1077 in a Phase 2, Placebo-Controlled, Double-Blind, Randomized Withdrawal Study in Patients with Idiopathic Hypersomnia ...

The company plans to advance ORX750 into Phase 2 studies for narcolepsy and idiopathic hypersomnia in Q4 2024. Centessa Pharmaceuticals plc CNTA released interim data from an ongoing Phase 1 trial ...

The company’s ORX750 drug has advanced Phase II studies for treating rare sleep disorders like narcolepsy and idiopathic hypersomnia. Moreover, positive interim data from Phase I studies showed ORX750 ...